| CXSL2300875 | SR604注射液 | SR-604 | Injection | Biological Products(1) | New Drug Application | 2023-12-22 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB2200147 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB1600073 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2016-11-02 | 上海莱士血液制品股份有限公司 | Shanghai RAAS Blood Products Co Ltd | Certificate Issued | 2017-06-20 | view |
| CYSB2200146 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB2200142 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB1600072 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2016-11-02 | 上海莱士血液制品股份有限公司 | Shanghai RAAS Blood Products Co Ltd | Certificate Issued | 2017-06-20 | view |
| CYSB1600068 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2016-11-02 | 上海莱士血液制品股份有限公司 | Shanghai RAAS Blood Products Co Ltd | Certificate Issued | 2017-05-26 | view |
| CYSB1600071 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2016-11-02 | 上海莱士血液制品股份有限公司 | Shanghai RAAS Blood Products Co Ltd | Certificate Issued | 2017-06-20 | view |
| CYSB2200148 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB1600075 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2016-11-02 | 上海莱士血液制品股份有限公司 | Shanghai RAAS Blood Products Co Ltd | Certificate Issued | 2017-06-20 | view |
| CYSB2200145 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB2200144 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB1600074 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2016-11-02 | 上海莱士血液制品股份有限公司 | Shanghai RAAS Blood Products Co Ltd | Certificate Issued | 2017-06-20 | view |
| CYSB2200143 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB1600070 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2016-11-02 | 上海莱士血液制品股份有限公司 | Shanghai RAAS Blood Products Co Ltd | Certificate Issued | 2017-05-26 | view |
| CYSB2200152 | 人凝血酶 | thrombin alfa | Other | Biological Products | Supplementary Application | 2022-06-10 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB2000295 | 人凝血酶 | thrombin alfa | Other | Biological Products | Supplementary Application | 2020-11-17 | 上海莱士血液制品股份有限公司 | Shanghai RAAS Blood Products Co Ltd | Certificate Issued | 2021-12-08 | view |
| CYSB2200244 | 人凝血酶原复合物 | human prothrombin complex | Lyophilized | Biological Products | Supplementary Application | 2022-10-12 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB2200140 | 人凝血酶原复合物 | human prothrombin complex | Lyophilized | Biological Products | Supplementary Application | 2022-06-08 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB2200245 | 人凝血酶原复合物 | human prothrombin complex | Lyophilized | Biological Products | Supplementary Application | 2022-10-12 | | Shanghai RAAS Blood Products Co Ltd | | | view |
